Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Treatment With Human Growth Hormone Increase Strength in Spinal Muscular Atrophy Type II and III?

NCT00533221 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.

NCT NCT00533221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00533221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Treatment With Human Growth Hormone Increase Strength in Spinal Muscular Atrophy Type II and III?
Lead sponsor
University Hospital Freiburg
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
August 31, 2011
Enrollment
20 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

muscular atrophy, spinal